Assessment of the Potential for Inducing Resistance in Multidrug Resistant Organisms From Exposure to Minocycline, Rifampin and Chlorhexidine Used to Treat Intravascular Devices.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00040-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

New Drugs to Treat Multidrug-Resistant Tuberculosis: The Case for Bedaquiline

Therapeutics and Clinical Risk Management
2014English

Multidrug Resistance: In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (Adv. Mater. 10/2018)

Advanced Materials
Mechanics of MaterialsMaterials ScienceNanotechnologyMechanical EngineeringNanoscience
2018English

Multidrug-Resistant Organisms on Patients’ Hands

JAMA Internal Medicine
Internal Medicine
2016English

Classification of Drugs to Treat Multidrug-Resistant Tuberculosis (MDR-TB): Evidence and Perspectives

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Linezolid Safety, Tolerability and Efficacy to Treat Multidrug- And Extensively Drug-Resistant Tuberculosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Can the Devices Used to Treat Obstructive Sleep Apnoea Syndrome Increase the Tendency to Gain Weight?

ENT Updates
2015English

Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units

2017English

A Case of Intravascular Lymphoma Complicated With Fournier's Syndrome Due to Multidrug-Resistant Pseudomonas Aeruginosa

Journal of clinical and experimental hematopathology : JCEH
Medicine
2011English

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used to Treat Infections With ESBL-positive Organisms

Journal of Clinical Microbiology
Microbiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy